木犀草素增強亞劑量卡托普利降壓作用并減少咳嗽的研究
[Abstract]:Background & objective: the effect of angiotensin converting enzyme inhibitor (ACEI) on antihypertension and protection of target organs has been recognized, but its disadvantage is that the incidence of irritating dry cough is high, so, It is of great clinical significance to reduce the incidence of cough with ACEI drugs. In view of the fact that luteolin not only has antihypertensive effect, but also has strong anti-inflammatory effect, which can reduce airway hyperresponsiveness and other pharmacological activities. The purpose of this study was to evaluate whether luteolin can enhance the antihypertensive effect of subdose captopril and reduce the adverse reactions of cough, and to explore the mechanism of interaction. Methods: 1) the rat model of renal hypertension was established, and the changes of blood pressure in tail artery of rats were detected. 2) the effect of sulfur dioxide on cough in mice was studied. 3) the model of airway hyperresponsiveness was established by atomization inhalation of ovalbumin. The contents of IL-4,IL-5 and IFN- 緯 in (BALF) of bronchoalveolar lavage fluid were determined by ELISA. 4) the metabolic activity of mouse macrophages was detected by MTT. 5) ELISA assay and NO kit were used to detect the secretion of IL-1 尾 by macrophages. The effects of IL-10,TNF-a and NO were detected by confocal laser scanning microscope. 6) the effects of drugs on the concentration of Ca2 and the change of pH in mouse macrophages induced by LPS were detected by laser confocal scanning microscope. The results were as follows: 1) Hypertension rats were divided into groups and blood pressure was measured. The results showed that the blood pressure of animals given captopril and rhinocerol decreased significantly from the 7th day. On the 14th day, the antihypertensive effect of subdose captopril combined with luteolin basically reached the effect of constant dose captopril. 2) the cough of mice increased with the increase of captopril dosage. Combined with lignogenin could reduce the incidence of cough in mice. 3) luteolin significantly decreased the levels of IL-4 and IL-5 in BALF model of hyperairway reactive mice, but captopril had no significant inhibitory effect. The combination of the two subdoses could inhibit the secretion of IL-4 and IL-5 and increase the level of IFN- 緯. 4) the metabolic activity of macrophages and the secretion of TNF-a,IL-1 尾 and IL-10 were significantly decreased by luteolin. Captopril had obvious inhibitory effect at high concentration, but no significant inhibitory effect at low concentration of captopril. The combination of them could inhibit the secretion of TNF-a,IL-1 尾 and IL-10 without synergistic effect, but had a certain additive effect. In addition, captopril and luteolin could inhibit the secretion of NO, but there was no synergistic effect. 5) luteolin and captopril significantly decreased intracellular Ca2 concentration and increased intracellular pH,. However, there was no significant synergistic effect on intracellular Ca2 concentration and pH. Conclusion: 1) the combination of subdose luteolin and subdose captopril can basically achieve the antihypertensive effect of constant dose captopril. 2) the combination of subdose captopril and luteolin can reduce the incidence of cough in mice caused by the former. The mechanism may be related to the decrease of captopril dose and the inhibition of IL-4,IL-5 secretion and the increase of IFN- level. Regulating the proportion of TH1 and TH2 cells is related. 3) although the combination of captopril and luteolin in vitro has no obvious synergistic anti-inflammatory effect, it has a certain additive effect. The anti-inflammatory effect of luteolin may be helpful to reduce the frequency of captopril cough. The anti-inflammatory mechanism may be related to the decrease of intracellular Ca2 concentration, the increase of pH value and the inhibition of macrophage secretion of pro-inflammatory cytokines.
【學位授予單位】:南方醫(yī)科大學
【學位級別】:碩士
【學位授予年份】:2017
【分類號】:R544.1
【參考文獻】
相關(guān)期刊論文 前10條
1 ZHANG Rui-qu;LI Dong-ye;XU Tong-da;ZHU Sha-sha;PAN Huan-jun;FANG Fang;WU Xin;SUN Hong;;Antioxidative Effect of Luteolin Pretreatment on Simulated Ischemia/Reperfusion Injury in Cardiomyocyte and Perfused Rat Heart[J];Chinese Journal of Integrative Medicine;2017年07期
2 趙長祺;郭志義;;木犀草素的藥理作用研究進展[J];承德醫(yī)學院學報;2015年02期
3 楊海平;孔一慧;李為民;;冠心病常用藥物的抗炎作用[J];國際心血管病雜志;2015年01期
4 張有志;龍豐;陳小東;;血管緊張素轉(zhuǎn)換酶抑制劑相關(guān)性咳嗽[J];中國呼吸與危重監(jiān)護雜志;2013年06期
5 梁雪;潘若凡;丁瑩;段富津;;麻杏枇杷顆粒對咳喘模型小鼠的影響[J];中醫(yī)藥信息;2013年03期
6 酆孟潔;邱晨;劉雯雯;;支氣管肺泡灌洗術(shù)在哮喘小鼠模型中的應用[J];國際檢驗醫(yī)學雜志;2012年19期
7 周麗嫦;徐艷燕;陳偉標;曾婉君;王葉茗;歐陽勇;;木犀草素預防高脂膳食誘導的小鼠胰島素抵抗的實驗研究[J];現(xiàn)代生物醫(yī)學進展;2012年14期
8 羅誠浩;宋旭艷;魏敏;陳義坤;劉華臣;王君;;黃芩苷、木犀草素混合物鎮(zhèn)咳祛痰平喘作用的實驗研究[J];世界中西醫(yī)結(jié)合雜志;2012年03期
9 任曉蕾;楊樂;李玉珍;;ACEI類藥物致不良反應分析及臨床合理用藥[J];中國醫(yī)院用藥評價與分析;2010年09期
10 張毅;王旭光;楊展;何惠娟;;木犀草素體內(nèi)抗炎作用機制研究[J];廣東醫(yī)學院學報;2009年06期
,本文編號:2477801
本文鏈接:http://sikaile.net/yixuelunwen/xxg/2477801.html